Total operating revenue increased 11.4% year over year to $8.5 billion for the six months ended Dec. 31. Officials said increases in net patient care revenue and premium revenue were key drivers.
Total operating expenses increased 7.8% year over year to $7.5 billion. The increase was largely attributed to increased volumes. Salaries, wages and benefits expenses increased 5.1%. Supplies and other operating expenses increased 9.8%.
The system had 297.1 days cash on hand as of Dec. 31, down from 298.3 on June 30. Its long-term debt was $4 billion as of Dec. 31, compared to $4.2 billion on the same date in 2023.
Baylor Scott & White reported a net income of $1.4 billion in the first half of 2025, up from $981 million over the same period last year.
Moody’s upgraded the system’s credit rating on Feb. 11 to “Aa2” from “Aa3.” The upgrade reflects consistently strong financial performance, driven by “deep and disciplined leadership” and favorable demographic characteristics, Moody’s said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
